American Capital Advisory’s Gilead Sciences GILD Stock Holding History

American Capital Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Buy	985 +20	+2%	+$2.63K	0.05%	134
2026 Q1	$134K	Buy	965 +7	+0.7%	+$980	0.05%	131
2025 Q4	$118K	Buy	958 +8	+0.8%	+$972	0.05%	136
2025 Q3	$105K	Hold	950	–	–	0.05%	133
2025 Q2	$105K	Buy	950 +19	+2%	+$2.02K	0.05%	125
2025 Q1	$104K	Buy	931 +911	+4,555%	+$94K	0.06%	122
2024 Q4	$1.85K	Hold	20	–	–	﹤0.01%	402
2024 Q3	$1.68K	Hold	20	–	–	﹤0.01%	397
2024 Q2	$1.62K	Hold	20	–	–	﹤0.01%	363
2024 Q1	$1.66K	Hold	20	–	–	﹤0.01%	380
2023 Q4	$1.62K	Buy	+20	New	+$1.56K	﹤0.01%	363

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

American Capital Advisory's GILD Position: Q2 2026 in Review

American Capital Advisory increased its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, buying an estimated $2.63K and bringing the position to 985 shares worth $124K. The position accounts for 0.05% of the portfolio, ranked #134.

American Capital Advisory first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $134K in Q1 2026. 885 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

American Capital Advisory held 985 shares of Gilead Sciences worth $124K as of Q2 2026.
American Capital Advisory bought 20 Gilead Sciences shares in Q2 2026, an estimated $2.63K.
Gilead Sciences made up 0.05% of American Capital Advisory's portfolio in Q2 2026, its #134 holding.
American Capital Advisory first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
American Capital Advisory's Gilead Sciences position peaked at $134K in Q1 2026.
885 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.